|
C2ORF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23390195230877E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65543143029845E-12 |
| Normal-vs-Stage2 |
2.13359999999829E-05 |
| Normal-vs-Stage3 |
1.403000E-03 |
| Normal-vs-Stage4 |
5.884200E-01 |
| Stage1-vs-Stage2 |
6.820600E-01 |
| Stage1-vs-Stage3 |
1.017850E-02 |
| Stage1-vs-Stage4 |
1.214760E-01 |
| Stage2-vs-Stage3 |
1.564600E-01 |
| Stage2-vs-Stage4 |
1.616360E-01 |
| Stage3-vs-Stage4 |
4.053200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.96389604368142E-12 |
| Normal-vs-AfricanAmerican |
4.32500000000502E-05 |
| Normal-vs-Asian |
1.095510E-02 |
| Caucasian-vs-AfricanAmerican |
8.299400E-03 |
| Caucasian-vs-Asian |
6.707800E-01 |
| AfricanAmerican-vs-Asian |
6.236400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81443748914489E-12 |
| Normal-vs-Female |
7.57290000000799E-05 |
| Male-vs-Female |
2.31389999999498E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.377800E-04 |
| Normal-vs-Extreme_Weight |
2.28759999831851E-09 |
| Normal-vs-Obese |
2.3521999999998E-06 |
| Normal-vs-Extreme_Obese |
5.032700E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.809700E-02 |
| Normal_Weight-vs-Obese |
7.945200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.116800E-01 |
| Extreme_Weight-vs-Obese |
8.981300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.348800E-01 |
| Obese-vs-Extreme_Obese |
5.224000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.271800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.54119999984381E-07 |
| Normal-vs-Age(61-80Yrs) |
1.51101353651484E-13 |
| Normal-vs-Age(81-100Yrs) |
2.24299999999067E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.357800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.413900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.150200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.257600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.775760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.252000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.00249999915414E-08 |
| Normal-VS-Type2 PRCC |
4.26049999946443E-07 |
| Normal-VS-KIRP CIMP |
8.480200E-01 |
| Normal-VS-Unclassified PRCC |
2.9863999999602E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.652200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.0806999999623E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
7.022600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.922200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.516600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.144200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.14010001229082E-09 |
| Normal-vs-N1 |
3.842000E-01 |
| Normal-vs-N2 |
1.143150E-01 |
| N0-vs-N1 |
2.096900E-03 |
| N0-vs-N2 |
1.713600E-01 |
| N1-vs-N2 |
4.858600E-01 |
|
|
